Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. [electronic resource]
- Expert opinion on biological therapy 06 2020
- 653-664 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1744-7682
10.1080/14712598.2020.1729735 doi
Adrenal Cortex Hormones--therapeutic use Antibodies, Monoclonal, Humanized--therapeutic use Antigens, CD19--immunology Cytokine Release Syndrome--drug therapy Humans Immunotherapy, Adoptive--adverse effects Neurotoxicity Syndromes--drug therapy Risk Factors Severity of Illness Index